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ABSTRACT 
 
Genomic DNA can be covalently modified by methylation, which is layered 
on the primary genetic information and alters gene expression. There are two 
patterns of DNA methylation. The first, stable methylation, seen in 
imprinting, is inherited in a sex-specific fashion and is invariant among 
individuals and cell types. Unstable or metastable methylation is variable 
among individuals and cell types and is associated with cancer and aging. The 
primary cause of somatic DNA methylation is not known. Here we show that 
DNA methylation is linked with transcription and repair. The effectors of 
DNA methylation are DNA methyltransferases (DNMTs) that catalyze either 
de novo or maintenance methylation of hemimethylated DNA during 
replication. Demethylation of DNA has recently been linked to BER 
enzymes, which remove mismatched or alkylated bases. CpG de-methylation 
is also associated with mC oxidation and marks transcription start sites (Zhu 
2009; Chen and Riggs 2011) . The aim of my study is to analyze the 
association between DNA methylation and Estrogen-dependent induction of 
transcription. The estrogens are hormones that bound to the receptors 
penetrate into chromatin-DNA and bind specific DNA sequence present in 
several sites in the genome. The active receptors bound to DNA, trigger 
oxidative demethylation of histones locally and induce DNA (G) oxidation 
(Perillo et al. 2008). Simultaneously, on the same sites DNMT1, 3a, DNA 
methyltransferase enzymes, are recruited and stimulate a wave of methylation 
of CpGs.  Methylated CpGs and oxidized Gs in the target sites during 
transcription initiation accumulate and are processed by BER and NER 
enzymes.  
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1. INTRODUCTION 
1.1 The Transcription Process 
Transcription is a cyclic process that transfers the genetic information of  the 
DNA into RNA. It can be roughly divided into three major steps – promoter 
DNA binding and RNA chain initiation, processive RNA chain elongation, 
and termination.  
DNA-dependent RNA polymerase (RNA pol) is the principal enzyme of gene 
expression in Eukaryota. RNA pol synthesizes the RNA chain 
complementary to the DNA template strand from nucleoside triphosphate 
(NTP) substrates. The first step of the cycle requires the presence of one of 
the promoter-specific subunits that together with the core forms the 
holoenzyme (Burgess and Anthony 2001; Wade et al. 2006). 
The holoenzyme involves 12–14 subunits (depending on the polymerase type 
and organism and when active on DNA, they are also typically complexed 
with other factors and catalyze the production of complementary RNA 
(Borukhov and Nudler 2008). 
Three different types of RNA polymerase exist in eukaryotic cells, whereas 
bacteria have only one. In eukaryotes, RNA pol I transcribes the genes that 
encode most of the ribosomal RNAs (rRNAs), and RNA pol III transcribes 
the genes for one small rRNA, plus the transfer RNAs that play a key role in 
the translation process, as well as other small regulatory RNA molecules. 
Thus, it is RNA pol II that transcribes the messenger RNAs, which serve as 
the templates for production of protein molecules (Clancy 2008).  
  
 
 
  
Figure 1: Visualizing Transcription.  
The process of transcription can be visualized by electron microscopy. In these early electron 
micrographs, the DNA molecules appear as "trunks," with many RNA "branches" extending out from 
them.  
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1.2 The three stages of DNA transcription 
 
The first step of transcription is initiation, when the RNA polymerase II 
(RNA pol II) binds to the promoter sequence, melts the DNA duplex around 
the transcriptional start-site to form the transcription bubble.  
This process called transcription initiation results in a stable open promoter 
complex, which initiates RNA synthesis (Figure 3a). 
Many eukaryotic genes possess enhancer sequences, which can be found at 
considerable distances from the genes they affect. Enhancer sequences 
control gene activation by binding with activator proteins and altering the 3-D 
structure of the DNA to help "attract" RNA pol II, thus regulating 
transcription. Since eukaryotic DNA is tightly packaged as chromatin, 
transcription also requires a number of specialized proteins that help making 
the coding strand accessible. 
In eukaryotes, the "core" promoter for a gene transcribed by RNA pol II is 
most often found immediately upstream (5′) of the start site of the gene. Most 
RNA pol II genes have a TATA box (consensus sequence TATTAA) 25 to 35 
bases upstream of the initiation site, which affects the transcription rate and 
determines location of the start site. Eukaryotic RNA polymerases use a 
number of essential cofactors (collectively called general transcription 
factors), and one of these, TFIID, recognizes the TATA box and ensures that 
the correct start site is used. Another cofactor, TFIIB, recognizes a different 
common consensus sequence, G/C G/C G/C G C C C, approximately 38 to 32 
bases upstream (Figure 2). 
 
          
 
 
 
Figure 2: The promoters of genes transcribed by RNA polymerase II consist of a core promoter and a 
regulatory promoter that contain consensus sequences. Not all the consensus sequences shown are 
found in all promoters. 
 
 
Enhancer sequences act to enhance the rate at which genes are transcribed. 
Enhancers can be thousands of nucleotides away from the promoters with 
which they interact, but they are brought into proximity by the looping of 
DNA. This looping is the result of interactions between the proteins bound to 
the enhancer and those bound to the promoter. The proteins that facilitate this 
looping are called activators, while those that inhibit it are called repressors  
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Once transcription is initiated and the RNA chain reaches 8–11 nucleotides 
(nt), the transition to productive elongation usually takes place, adding 
nucleotides to the 3’ end of the growing chain (Figure 3b) (Borukhov and 
Nudler 2008). 
In eukaryotes, termination of transcription occurs by different processes, 
depending upon the exact polymerase utilized.  
Transcription of RNA pol II genes can continue for hundreds or even 
thousands of nucleotides beyond the end of a coding sequence. The RNA 
strand is then cleaved by a complex that appears to associate with the 
polymerase. Cleavage seems to be coupled with termination of transcription 
and occurs at a consensus sequence (Figure 3c) (Clancy 2008). 
 
 
                 
 
Figure 3: (A) The transcription process is initiated when the enzyme RNA polymerase binds to a DNA 
template at a promoter sequence. (B) During the elongation process, the DNA double helix unwinds. 
RNA polymerase reads the template DNA strand and adds nucleotides to the three-prime (3’) end of a 
growing RNA transcript. (C) When RNA polymerase reaches a termination sequence on the DNA 
template strand, transcription is terminated and the mRNA transcript and RNA polymerase are released 
from the complex (© 2013 Nature Education All rights reserved.). 
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1.3 Epigenetics 
Epigenetics is considered as heritable changes in gene expression that do not 
consist of changes in DNA sequence.  
Epigenetic changes are involved in development and differentiation and one 
example is the X-chromosome inactivation in female mammals. However, 
epigenetic states can become altered by environmental influences or during 
ageing, leading to the develop of cancer and other diseases.  
Examples of mechanisms that produce such changes are DNA methylation 
and histone modification, each of which alters how genes are expressed 
without altering the underlying DNA sequence.  
These epigenetic changes may last through cell divisions for the duration of 
the cell's life, and may also last for multiple generations even though they do 
not involve changes in the underlying DNA sequence of the organism (Bird 
2007)  
 
1.3.1 Histone modifications 
 
Eukaryotic chromatin contains DNA and histones that are organized in the 
nucleosome, which consists of a histone octamer (two H2A/H2B dimers and 
an H3/H4 tetramer), around which ~146 bp of DNA is wrapped. Most 
chromatin exists as transcriptionally ineffectual heterochromatin, in which 
the nucleosomes are densely packaged to form a ‘closed chromatin structure’. 
Conversely, an ‘open chromatin structure’ is characteristic of transcriptionally 
competent euchromatin, which has widely spaced nucleosomes and is 
accessible to the transcriptional machinery. Accordingly, euchromatic 
chromatin is flexible to meet the requests for individual proteins under 
particular cellular circumstances. 
The terminal tails of these histones can be modified by methylation and 
acetylation, which are critical for the regulation of gene transcription. 
Together, these modifications result in a complex series of molecular events 
that cause re-modelling of the chromatin configuration and render genes 
either active or silent. 
 
Histone acetylation: 
 
Chromosomal processes such as transcription are influenced by a variety of 
post-translational modifications to histones, including acetylation, 
phosphorylation, methylation, and ubiquitination. Methylated CpG islands 
attract a group of repressive proteins, the so-called methyl-CpG-binding-
domain proteins, in a complex  with histone deacetylases, which remove 
acetyl groups from lysine residues in the histone tails. 
 Deacetylated lysines are positively charged and react strongly with the 
negatively charged DNA. This leads to dense condensation of the 
nucleosomes at transcriptionally inactive promoters. Conversely, acetylation 
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of the lysines neutralizes this charge, which generates the open chromatin 
structure at transcriptionally active promoters. Histone acetylation is mediated 
by histone acetyl transferases, which form a ‘transcription activator complex’ 
with transcription factors and co-activator proteins. Histone acetylation is 
catalyzed by histone acetyltransferases (HATs) and histone deacetylation is 
catalyzed by histone deacetylases (denoted by HDs or HDACs).  Several 
different forms of HATs and HDs have been identified.  Among them, 
CBP/p300 is probably the most important, since it can interact with numerous 
transcription regulators. 
 
                        
  
                         Figure 4.  Acetylation and deacetylation of the lysine residue. 
 
In addition to acetylation, a number of different covalent histone 
modifications have been identified that mark the transcriptional status of 
chromatin. 
 
Histone methylation: 
 
Histone lysines may be unmethylated, or mono-, di- or trimethylated (-me1, -
me2, -me3). The level of methylation at particular residues is important for 
the interaction with cofactors and is therefore essential for regulation of 
transcriptional activity. Repressive marks include di- and trimethylation of 
lysine 9 on histone H3 (H3K9me2/me3), trimethylation of lysine 27 on 
histone H3 (H3K27me3) and trimethylation of lysine 20 on histone H4 
(H4K20me3). Conversely, activation is associated with histone H3 di- and 
trimethylation of lysine 4 (H3K4me2/me3) and trimethylation of lysines 36 
and 79 (H3K36me3, H3K79me3). Methyl groups are provided to the histones 
by SAM/Ado-Met and the methylation reaction is catalysed by histone lysine 
methyltransferases. Methyl groups can also be removed from histone lysine 
residues by the action of histone lysine demethylases (Gronbaek et al. 2008). 
It has been shown that transcriptional activation is linked to H3K4 
methylation cycle  and the enzyme involved in this process is the lysine-
specific demethylase.  
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LSD1 is a flavin adenine dinucleotide (FAD)-containing enzyme, which 
demethylates di-methyl lysine 4  (or lysine 9 under certain conditions) and 
generates H2O2 during the demethylation process (Anand and Marmorstein 
2007; Gronbaek et al. 2008; Lan et al. 2008). It has been shown that transient 
demethylation of histone H3 lysine 4 triggers Myc-induced transcription 
(Amente et al. 2010). Also, it has been found that Estrogen-Induced Gene 
Expression is driven by H3K9me2 demethylation (Perillo et al. 2008). In both 
cases LSD1 is responsible for the oxidative process that results in the 
formation of Hydrogen peroxide (H2O2) whose main DNA product is 8-oxo-
guanine (8-oxo-G). 8-oxo-G is removed by base excision repair (BER) 
enzymes that seem to be an important signal driving transcription initiation. 
More specifically, 8-oxo-G is recognized and removed by the 8-oxo-guanine-
DNA glycosylase 1 (OGG1) that leaves an apurinic site, further processed by 
the nuclease Ape 1 (Amente et al. 2010). Ape1 may be important during the 
initiation process, because it introduces nicks in the chromatin that can 
dynamically dissipate transcription-induced supercoiling (Bhakat KK et al. 
2008;  Chattopadhyay et al. 2008).  
Because it has also been shown that topoisomerase ΙΙ recognizes and repairs a 
single-stranded DNA break in double-stranded substrates, it has been 
proposed that removal of the oxidized bases generates transient nicks that 
function as entry points for the enzyme. In this way, topoisomerase IIb 
relaxes the DNA strands and favors chromatin bending to accommodate the 
transcription initiation complex (Perillo et al. 2008).  
 
 
1.3.2 DNA Methylation and Demethylation in Mammals  
 
DNA methylation occurs almost entirely within CpG dinucleotides. In 
general, 5mC is highly frequent in repetitive sequences and in gene bodies but 
rare housekeeping promoters. 
DNA methylation is also involved in genomic imprinting, X chromosome 
inactivation, and suppression of retrotransposon elements, and is essential for 
normal development.  
Although methylation patterns are largely maintained through somatic cell 
divisions, changes in methylation patterns occur during mammalian 
development and cell differentiation (Chen and Riggs 2011).  
 
 
DNA Methylation Mechanism  
 
The effectors of DNA methylation are DNA methyltransferases (DNMTs) 
that catalyze either de novo or maintenance methylation of hemimethylated 
DNA during replication. These enzymes catalyze the transfer of a methyl 
group fromS-adenosyl-L-methionine to cytosine, DNMT1, probably with the 
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help of UHRF1, recognizes hemimethylated sites and copies pre-existing 
methylation patterns to the newly synthesized strand.  
DNMT3A and DNMT3B are de novo methyltransferases active on 
unmethylated DNA (Fig. 6). They are important during early development 
and also contribute to the maintenance of DNA methylation sites missed by 
DNMT1. 
DNMT3L lacks critical methyltransferase motifs and is catalytically inactive, 
but it can stimulate the activity of DNMT3A/3B.  
Moreover, it has been reported that specific histone modifications, such as 
H3K4 methylation may protect DNA from de novo methylation (Chen and 
Riggs 2011).  
 
           
 
 
Figure 5. Mechanisms of DNA methylation and demethylation in mammals. A. DNMTs catalyze the 
covalent addition of a methyl group to C-5 of cytosine. B. There are two DNMT activities: de novo and 
maintenance methylation. DNMT3A and DNMT3B are de novo methyltransferases that establish 
methylation patterns during early development then maintained through somatic cell divisions by the 
maintenance methyltransferase DNMT1 (Chen and Riggs 2011).  
14 
 
        
 
 
Figure 6. Schematic structure of human DNMTs and DNMT3-like protein.  
Conserved methyltransferase motifs in the catalytic domain are indicated in Roman numerals. NLS, 
nuclear localization signal; RFT, replication foci-targeting domain; BAH, bromo-adjacent homology 
domain;PWWP, a domain containing a conserved proline-tryptophan-tryptophan-proline motif; PHD, a 
cysteine-rich region containing an atypical plant homeodomain; aa, amino acids. DNMT3L lacks the 
critical methyltransferase motifs and is catalytically inactive (Chen and Riggs 2011). 
 
 
Mechanisms of Active DNA Demethylation  
 
DNA demethylation can be achieved either passively, by simply not 
methylating the new DNA strand after replication, or actively, by a 
replication-independent process (Fig. 5B). However, the mechanism(s) of 
active demethylation remain poorly understood. Fig. 7 proposes three 
possible mechanisms of active DNA Demethylation. Only in plants is there 
firm evidence for the direct removal of the 5mC base by a 5mC-specific 
glycosylase (DME/ROS1family) (Zhu JK. 2009). This process is like base 
excision repair (BER) and  together with other evidence, it has been 
suggested a role for BER in active demethylation in mammals but, only weak 
5mC glycosylase activity has been reported for thymine DNA glycosylase 
(TDG) and methyl-CpG-binding domain protein 4 (MBD4). 
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 Otherwise, it has been proposed that BER enzymes are involved only after 
modification of the 5mC base. An example of this suggested mechanism is 
deamination of 5mC to thymine, followed by BER of the resulting T-G 
mismatch (Fig. 7). Activation-induced cytosine deaminase (AID) and 
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 (APOBEC1) 
can deaminate 5mC, the resulting T-G mismatches are then repaired and the 
unmethylated C is restored.  
 Recently, it has been discovered that mouse and human TET family proteins 
can catalyze conversion of 5mC to 5hmC, a new modified base found in 
mammalian DNA. This observation suggests that 5hmC could be an 
intermediate in active demethylation and repaired by a BER process, 
although, so far, no 5hmC DNA glycosylases have been identified (Chen and 
Riggs 2011). 
 
 
 
 
 
Figure 7. Models for DNA demethylation mechanisms involving BER (Chen and Riggs 2011). 
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1.4 Estrogen induced transcription  
Estrogen (17β-estradiol) is the primary female sex hormones. Natural 
estrogens are steroid hormones, and readily diffuse across the cell membrane. 
Once inside the cell, they bind to and activate estrogen receptors which in 
turn modulate the expression of many genes (Nussey and Whitehead 2001). 
Two classes of estrogen receptor exist: ER, which is a member of the nuclear 
hormone family of intracellular receptors, and GPR30, which is a member of 
the rhodopsin-like family of G protein-coupled receptors.  
Once activated by estrogen, the ER is able to translocate into the nucleus and 
bind to DNA to regulate the activity of different genes (i.e. it is a DNA-
binding transcription factor). Estrogen receptor has two different forms, α and 
β, encoded by a separate gene (ESR1 and ESR2, respectively).  
Upon binding to 17β-estradiol (E2), ER forms dimers, ERα (αα) or ERβ (ββ) 
homodimers or ERαβ (αβ) heterodimers  and interacts with permutations of a 
palindromic DNA sequence separated by three nonspecific nucleotides: 5′-
GGTCAnnnTGACC-3′, the consensus estrogen responsive element (ERE) (Li 
et al. 2004).  
The E2-ER-ERE complex subsequently recruits coactivators/regulators to 
promote local chromatin remodeling and the initiation of transcription. This 
pathway is called ERE-dependent ER signaling.  
Estrogen receptor alpha and beta show significant overall sequence 
homology, and both are composed of five domains (listed from the N- to C-
terminus; amino acid sequence numbers refer to human ER):(A-F domain) 
 
          
 
 
 Figure 8: The domain structures of ERα and ERβ, including some of the known phosphorylation sites 
involved in ligand-independent regulation. 
 
 
 
The N-terminal A/B domain is able to transactivate gene transcription in the 
absence of bound ligand (e.g., the estrogen hormone) but this activation is 
weak and more selective compared to the activation provided by the E 
domain. The C domain, also known as the DNA-binding domain, binds to 
estrogen response elements (ERE) in DNA.  
The D domain connects the C and E domains.  
17 
 
The E domain contains the ligand binding cavity as well as binding sites for 
coactivator and corepressor proteins.  In the presence of bound ligand it is 
able to activate gene transcription.  
The C-terminal F domain function is not entirely clear and is variable in 
length (Li et al. 2004).  
. 
 
                 1.5  PS2 gene 
Trefoil factor 1 is encoded in humans by the TFF1 gene (also called PS2 
gene). 
The PS2 gene product is a small, secreted polypeptide currently of unknown 
function, but with structural features similar to some growth factors. In the 
human breast cancer cell line, ER stimulates PS2 gene transcription by 
interacting with an ERE in the 5'-flanking region of that gene.  It contains two 
regions required for the transcription-activating function of the ER, a DNA-
binding domain, which determines target gene specificity, and a hormone-
binding domain (Stack et al. 1988).  
 
 
 
 
Figure 9: PS2 gene structure.  It contains 3 exons and an Estrogen Responsive Element in the 5'-
flanking region of that gene.  
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2. AIM OF MY STUDY 
 
 
 The ultimate objective of this study is the analysis of the mechanism of 
transcription induction by activated estrogen receptor. 
 I wish specifically to find the role and the function of DNA methylation at 
the promoters of estrogens-induced genes during transcription initiation.  
 I have used a simplified system to analyze E2-induced transcription: PS2 
gene, which is induced by E2 and other factors and contains an estrogen 
responsive element ( ERE ) in the in the 5'-flanking region (Figure 9). 
 I have analyzed:  
1. the histone H3 methylation code before and after E2 stimulation;  
2. the timing of DNMTs recruitment on PS2 ERE elements associated with 
the induction of transcription;  
3. the different role of DNMT1 and 3a in transcription and replication.  
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3. MATERIAL AND METHODS 
 
Cell culture and drugs 
 
MCF-7 cells were cultured in Dulbecco’s-Modified-Eagle’s-Medium 
(DMEM) low glucose with 10%  Fetal Bovine Serum. Cells were counted 1 
million for plate and after 2 days hormone starved for other 3 days. To induce 
entry into the cycle, synchronized G0 arrested cells were treated with 50nM 
of E2  (Sigma-Aldrich) at the times indicated in the text. 
To synchronize RNA transcription, α-amanitin (Sigma-Aldrich) was used at 
the concentration of 2.5 µM, 2h before E2 treatment. 
1 µM of aphidicolin (Sigma-Aldrich) for 16h was added to hormone starved 
MCF 7 cells to block the replicative fork. 
 
 
 
mRNA quantification by qPCR 
 
cDNA was prepared from total RNA with Quantitect Reverse Transcription 
Kit (Qiagen, Milan, Italy) according to the manufacturer’s instructions. Each 
sample was assayed in triplicate. The qPCR data were normalized to the 
expression of the 18S gene, and after normalization, the data were presented 
as fold change relative to the 0 point. 
 
 
Transfections and silencing 
 
To carry out transient transfection experiments in MCF-7 cells, we used 
MicroPorator Digital Bio Technology, a pipettetype electroporation (Seoul, 
Korea). After 24h of hormone starvation, specific plasmids or shRNA were 
introduced into each 3x10^6 dissociated cells in 100 ml volume according to 
the manufacturer’s instructions. Pulse width was determined according to 
applied voltages: 1100V, 30 ms, 1 pulse. Electroporated cells were then 
seeded into 100-mm culture dishes containing 5ml of culture media. After 48 
h, cells were treated with E2 (Sigma-Aldrich) at the times and concentrations 
indicated in the text. 
 shRNA-DNMT1i(3'UTR) from Addgene, pc1099: DMNT1 wt, pc1078: 
DNMT1 mutant (C1229W) were used a final concentration of 2 µg for each 
transfection.  
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Chromatin immunoprecipitation (qChIP) 
 
 MCF-7 cells were hormone starved for 3 days and treated with E2 for the 
indicated times. After PBS wash, cells were cross-linked with a 1% formalde-
hyde/PBS solution for 10 min at room temperature. Cross-linking was 
stopped by adding glycine 125mM  for 5’ and samples were processed using 
the chromatin immunoprecipitation (ChIP) assay kit (Upstate Biotechnology) 
according to the manufacturer’s protocol. Antibodies used in these 
experiments were specific for DNMT1 and 3a (abcam), RNA POL II P-Ser5 
(Covance), gamma H2AX (cell signaling). Immunoprecipitated DNA was 
analyzed by PCR using sets of primers against PS2 ERE regions. PCR 
products were analyzed by semiquantitative and quantitative Real-Time PCR 
as indicated in the text. Normal serum and input DNA values were used to 
subtract/normalize the values from ChIP samples. All values represent the 
average of at least three independent experiments. 
 
 
AzadC trapping procedure 
MCF-7 cells were hormone starved for 3 days and treated with 2h of α-
amanitin before E2 induction at the indicated times. 15’-30’ before E2 
treatment cells had a pulse of 50 µM of 5-aza-2′-deoxycytidine. After PBS 
wash, cells were collected and genome extraction was performed using the 
MB buffer as indicated in the published protocol (Kiianitsa and Maizels 
2013). The genome was then sonicated and immunoprecipitated according 
with the ChIP assay procedure from Upstate Biotechnology. Antibodies used 
in these experiments were specific for DNMT1 and DNMT3a (abcam). 
Immunoprecipitated DNA was analyzed by PCR using sets of primers against 
PS2 ERE regions. PCR products were analyzed by semiquantitative and 
quantitative Real-Time PCR as indicated in the text. Normal serum and input 
DNA values were used to subtract/normalize the values from ChIP samples. 
All values represent the average of at least three independent experiments. 
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4. RESULTS 
Estrogen induces PS2 mRNA expression  
 
To verify the estrogen induction of transcription, we have first analyzed PS2 
mRNA levels after E2 stimulation. MCF-7 cells have been hormone-starved 
for 3 days and then treated with E2. Total RNA has been extracted and 
reverse transcribed into cDNA and then amplified with specific primers for 
PS2 mRNA. The results shown in Figure 10 indicate that at 60’ after E2 
activation, mRNA levels are significantly increased. 
 
 
                    
 
Figure 10: PCR analysis of PS2 mRNA levels in MCF-7 hormone-starved cells at 0’ and 60’ after E2 
activation. mRNA levels were normalized to 18S RNA levels. All values represent the average of at 
least three independent experiments. Differences between treatments were tested for statistical 
significance using Student’s matched pairs t test: *P<0.05 as compared with the each untreated control. 
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Transcriptional cycle induced by Estrogen 
 
 Estrogen Receptor α (ERα) belongs to the nuclear receptor superfamily of 
transcription factors (Robinson-Rechavi et al. 2003) and binds to cognate 
DNA sequences (estrogen responsive elements,  ERE). The binding of 
estradiol (E2) into a carboxy-terminal hydrophobic pocket of ERα induces 
three-dimensional changes of surfaces that interact with cofactors 
(Brzozowski et al. 1997). Studies using chromatin immunoprecipitation 
(ChIP) demonstrated that, once recruited to target promoters, E2-bound ERα 
induced an ordered, cyclical recruitment of coactivator complexes, some of 
which contain HAT, HMT or ATP-dependent remodelling activities (Metivier 
et al. 2003). To assess ERα and RNA pol II occupancy on PS2 Promoter/ 
ERE genomic sites in a precise temporal frame after E2 activation, we carried 
out qChIP analysis. The cells were hormone starved for 3 days and then 
treated with E2 at different times (0’, 15’, 30’, 45’, 60’). Figure 11 shows that 
ERα and RNA pol II are recruited (15’–60’) on the Promoter/ ERE of PS2 
gene and accumulate progressively. The transcriptional coactivators and 
acetyltransferases p300 and CREB binding protein (CBP) are also recruited to 
these regions after 30’-45’, respectively. Comparing the relative site 
occupancy of ER, RNA pol II on Promoter/ERE elements, we suggest a 
transcription cycle induced by E2 with a period of 45’–60’. The MBD-
containing proteins (MeCP2 and MBD2) appear late after E2 activation, 
probably acting as structural proteins, which recruit a variety of histone 
deacetylase (HDAC) complexes and chromatin remodelling factors, leading 
to chromatin compaction and, consequently, to transcriptional repression 
(REF).  
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Figure 11: Transcriptional cycle induced by Estrogen (Perillo et al. 2008) 
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Estrogen induces H3K9 demethylation on ERE chromatin. 
The ERα is rapidly recruited to the ERE chromatin of MCF-7 cells at 30’ – 
60’ of E2 addition (Figure 11) and acetylated H3 accumulates on the same 
sites (Fig 11). In this time frame (30’ – 60’) on the same promoter- ERE sites, 
independently on the physical distance on linear DNA, total and active (Ser 5-
phosphorylated) RNA Pol II accumulate (Figure 11). To find specific histone 
marks, linked to E2 induced transcription, we analyzed the histone H3 
methylation of lysine 4 (K or k 4) or 9 (K9) in MCF7 cells exposed to E2 for 
short periods of time. We performed ChIP experiments, using H3K9 and K4 
antibodies and specific primers for PS2 ERE regions. We show that E2 
induces a cycle of H3K4 methylation and H3K9 demethylation of 15 – 30’ 
(Figure 12c).  
Conventionally, methylation of lysine 4 in histone H3 (H3K4) marks 
transcribed loci, while the presence of dimethyl-lysine 9 in the same histone 
(H3K9me2) usually results into silencing.  
The analysis of the methylation status of H3 K4 and K9 indicates that:  
1. H3K4me2 disappears from the ERE chromatin (Figure 12b);  
2. the 3methyl form of H3K4 significantly increases (Figure 12b);  
3. H3K9 both me2 and me3 levels are significantly reduced on the  chromatin 
(Figure 12a).  
 These data indicate that E2 induces methylation of H3K4 and demethylation 
of H3K9 on the ERE chromatin. 
 
 
Figure 12:  PS2 H3 me k4 levels  are analyzed by qChIP in hormone-starved MCF-7 cells and after E2 
activation at the indicated times (Perillo et al. 2008). 
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H3K4/K9 methylation-demethylation cycle corresponds to the DNMTs 
recruitment on PS2 EREChromatin. 
 
It has been reported that DNMTs-dependent variations of the methylation 
status of CpGs within the PS2 gene promoter are integral components of the 
‘transcriptional clock’(Metivier et al. 2003) that controls the progression 
through transcription cycles. 
 We hypothesize that DNA methylation and transcription are closely linked. 
More specifically, DNA methylation changes at the transcription start sites 
and ERE (estrogen-responsive element) of E2-induced genes following short 
term (minutes) induction by estrogens, suggest that DNA methylation is 
essentail for progression of transcription. 
 The effectors of DNA methylation are DNA methyltransferases (DNMTs) 
that catalyze either de novo or maintenance methylation of hemimethylated 
DNA during replication.  
 We asked whether DNA methylation during E2-induced transcription was 
carried out by DNMT1 and 3a enzymes. To this end, we performed ChIP 
analysis, using DNMT1 and DNMT3a antibodies and specific primers for 
PS2- ERE regions.  
 Fig. 13a shows the recruitment of DNMT1 and DNMT3a on PS2 -ERE. 
Specifically, DNMT3a accumulates after 30’of E2 induction of transcription, 
while DNMT1 decreases on the same region. 
To confirm these data, we searched, on the same regulatory region, for the  
presence of Np95, (also known as UHRF1 or ICBP90), a protein that binds 
and anchors DNMT1 (Fig13b). As expected, Np95 decreases similarly to 
DNMT1(Fig.16c). 
 DNA methylation seems associated to histone H3 methylation cycles, 
because its timing (15’) overlaps with demethylation of histone H3 lysine 9 
and methylation of lysine 4 occurring in the first round of transcription 
induced by E2 (Fig 12). 
  To better investigate the specificity of DNMTs cyclic recruitment during E2 
induction of transcription, we analyzed the presence of DNMTs on H19 gene. 
H19 encodes a 2.3-kb non-coding mRNA which is strongly expressed during 
embryogenesis and it is not E2 responsive. 
 DNMT3a levels are stable and remain unmodified on H19 gene, indicating 
that DNMTs recruitment to the PS2 ERE is associated to active transcription. 
We do not know at present why DNMT1 disappears from H19 gene at 30’ of 
E2 (Fig 13b). We speculate that a late replication origin close to H19 gene 
promoter is induced by E2. 
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Figure 13: DNMTs levels were analyzed by qChIP in hormone-starved MCF-7 cells after E2 activation 
at the indicated times (15’, 30’). DNMT1 and DNMT3a show a different recruitment on PS2 ERE 
elements. 
ChIP with anti Np95 antibodies on PS2 ERE, (also known as UHRF1 or ICBP90), a protein that binds 
and anchors DNMT1 (Fig16b). Differences between treatments were tested for statistical significance 
using Student’s matched pairs t test: *P<0.05 as compared with the each untreated control. 
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The block of RNA pol II anticipates DNMT3a recruitment 
 
To better investigate the association between methylation and transcription, 
MCF7 cells were treated with α-amanitin (α-ama), an inhibitor of RNA pol II.  
α-ama is a cyclic peptide of eight amino acids that interacts with the bridge 
helix in RNA pol II. The bridge helix has evolved to be flexible and its 
movement is required for translocation of the polymerase along the DNA 
backbone. The addition of this drug reduces the rate of RNA pol II 
translocating on DNA (fig 14a). 
After 2h of α-ama treatment, we searched for the presence on the ERE 
chromatin of  DNMT1 and DNMT3a following E2 induction at short times.  
Figure 15c shows that DNMT3a was still recruited after E2 addition but it 
accumulated earlier, because α-ama synchronizes the first round of 
transcription. DNMT1 recruitment in the first 30’ of E2 is not modified by the 
drug (Fig15c).  
To confirm these data we evaluated the DNMT1 partners, Np95, recruitment 
under the same conditions. As expected, similarly to DNMT1, α-ama 
treatment did not modify Np95 binding on  ERE (Fig15a-c). 
 
 
 
 
Figure 14: α-ama reduces the rate of RNA pol II translocation on DNA. a. Ser5-P RNA pol II is 
responsible of transcription initiation and its recruitment has been analyzed by qChIP in hormone-
starved MCF-7 cells after 2h α-ama  and E2 activation at the indicated times (15’, 30’, 45’, 60’). b. 
Ser5-P RNA pol II recruitment by qChIP in hormone-starved MCF-7 cells after E2 treatment at the 
indicated times (15’, 30’, 45’, 60’). Differences between treatments were tested for statistical 
significance using Student’s matched pairs t test: *P<0.05 as compared with the each untreated control. 
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Figure 15: DNMTs cyclic recruitment to ERE chromatin after α-ama synchronization of transcription. 
DNMT1 and DNMT3a follow a similar kinetics in the first 30’ of  E2 activation. Differences between 
treatments were tested for statistical significance using Student’s matched pairs t test: *P<0.05 as 
compared with the each untreated control. 
 
We suggest that the recruitment of DNMT1-3a to the ERE, previously 
observed (Fig 13a), reflects two different events that occur in the same 
region, DNA transcription and DNA replication. Since DNMT1, is an 
important component of a multiprotein DNA replication complex, its 
recruitment can be linked to the action of DNA Polymerase. On the other 
hand, DNMT3a accumulation at 15’ – 30’ corresponds to the first round of 
transcription. Synchronization of transcription, by α-ama, confirms DNMT3a 
as the main actor in the E2- induction of transcription. However, the role of 
DNMT1 in E2-dependent transcription remains still to be elucidated. 
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A new procedure to detect DNMTs presence on chromatin 
 
 To confirm DNMT3a estrogen-dependent recruitment to ERE region, we 
performed a new experimental procedure by exploiting the ability of DNMTs 
enzyme to bind covalently  5-azacytidine. 
Azacitidine (5-azacytidine) is a chemical analogue of the cytosine nucleoside 
used in DNA and RNA. 5-aza-2′-deoxycytidine-triphosphate is a substrate for 
the DNA replication machinery and can be incorporated into DNA. 
Azacytosine-guanine dinucleotides are recognized by the DNA 
methyltransferases as natural substrate and the enzymes will initiate the 
methylation reaction by a nucleophilic attack. This results in the 
establishment of a covalent bond between the carbon-6 atom of the cytosine 
ring and the enzyme and its DNA methyltransferase function is permanently 
blocked (Stresemann and Lyko 2008) 
 Furthermore, it has been reported that E2 induce a burst of DNA oxidation 
on the promoter and ERE region of E2-responsive genes that is  recognized 
by BER enzymes generating transient nicks at the G-C pairs before the final 
substitution with new nucleotides (Perillo et al. 2008). 
Taking in mind this mechanism, we asked whether a short pulse of 15’ – 30’ 
min of 5-aza-2′-deoxycytidine was enough to incorporate the drug stably into 
the DNA at the ERE or promoter. In this case the covalent bond between the 
azacytosine ring and the DNMTs allows the immunoprecipitation of the 
enzyme without crossilinking with formaldehyde. 
 Fig.16 shows the DNMT3a “trapping” after 15 min of E2 induction , which 
confirms the previous data obtained by ChIP (Fig. 15). 
 
 
 
 
Figure 16: DNMTs “trapping” technique. A new procedure to capture these enzymes on DNA 
regulatory regions. This assay confirms  DNMT3a occupancy on PS2 ERE  elements at 15’ min of E2 
activation of transcription. Differences between treatments were tested for statistical significance using 
Student’s matched pairs t test: *P<0.05 as compared with the each untreated control. 
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DNA polymerase alpha inhibition by aphidicolin does not alter DNMT3a 
Estrogen- dependent cycle  
 
We speculate that DNMT1 accumulation on PS2 ERE is affected by DNA 
replication, while DNMT3a is mainly involved in the induction of 
transcription. To this end, we have specifically inhibited DNA Polymerase 
A,D with aphidicolin in MCF7 and analyzed again the presence of DNMT3a 
and DNMT1 on the same regions of PS2 gene at the same times of E2 
treatment. 
Fig. 17a-b, shows that the DNMT3a, accumulates also in the presence of 
aphidicolin with the same kinetics illustrated above (Fig 15,16), suggesting 
that the block of replication does not affect the recruitment of DNMT3a 
during transcription. Furthermore, these results indicate that DNMT1 is 
cyclically recruited after 30’ of E2 despite the inhibition of DNA replication. 
Probably, DNMT1 acts both in replication and transcription and the delayed 
recruitment visible in presence of aphidicolin, is dependent on transcription 
only, being replication completely blocked.  
                        
 
 
Figure 17: DNMTs Estrogen- dependent cycle in presence of DNA polymerase alpha inhibition, 
aphidicolin.  a. b. DNMTs levels by qChIP in hormone-starved MCF-7 cells after 16h of aphidicolin 
and E2 activation at the indicated times (15’, 30’, 45’, 60’). DNMT1 and DNMT3a show a different 
recruitment to the PS2 ERE element. c. DNMT1 and DNMT3a are unmodified in H19 gene which  is 
not E2 sensitive. Differences between treatments were tested for statistical significance using Student’s 
matched pairs t test: *P<0.05 as compared with the each untreated control. 
31 
 
Perturbation of DNA methylation waves, alters the Estrogen-dependent 
induction of Transcription. 
 Our previous results indicate that DNMT1 accumulation on Ps2 ERE is 
dependent on DNA replication, but the importance of this enzyme in the 
progression of transcription is reported in Fig.18, in which E2 induce 
transcription was analyzed in DNMT1 depleted cells. 
We knocked down DNMT1 levels with a specific shRNA-DNMT1i(3'UTR) 
in MCF7 cells induced with E2. Transcription of PS2 gene was significantly, 
inhibited when DNMT1gene was silenced (Fig. 18). Furthermore, expression 
of the wild type DNMT1 gene restored E2 induction of transcription. 
Transfection of the DNMT1 catalytic mutant (DNMT1 mutant (C1229W), in 
silenced cells, did not restore the E2 induction of transcription (Fig. 18).  We 
wish to note that overexpression of the wild type or mutant DNMT1 in 
normal cells (without depletion of the endogenous enzyme) inhibits E2 
induction of PS2 gene, suggesting that higher levels of the protein, 
independently on its activity, alters transcription probably by inducing 
“squelching” of the initiation complex (Fig. 18). 
 
 
 
Figure 18. E2 induction of PS2 gene expression and DNMT1 levels. Hormone starved MCF 7 cells 
were transfected with shRNA-DNMT1i(3'UTR), wt and a catalytic mutant (See Methods). After 48h, 
MCF-7 cells were treated for 60’ with E2. PS2 expression was analyzed by qPCR. mRNA levels were 
normalized to 18S RNA levels. All values represent the average of at least three independent 
experiments. Differences between treatments were tested for statistical significance using Student’s 
matched pairs t test: *P<0.05 as compared with the each untreated control. 
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 Phosphorylated H2AX accumulates at the E2-dependent promoter is 
dependent on DNA replication 
 Estrogen-transcriptional activation triggers DNA methylation/demethylation 
cycles (Fig. 13, 15) and DNA (dG) oxidation resulting in transient single 
strand nicks (Perillo et al. 2008). It has been reported that also double strand 
breaks can occur at the ERE sites (Chunru et al. 2009). However, the 
mechanism leading to these lesions is not known. 
We hypothesize that DNA replication may favour DNA polymerase and RNA 
polymerase collisions and generate local DSBs.  The best method to identify 
DSBs is the accumulation of H2AX phosphorylated (γH2AX) by the 
checkpoint kinases ATM or ATR.  
To this end we searched on PS2 ERE chromatin for the presence of γH2AX, 
after short times of E2 induction, in presence or in absence of the DNA Pol 
inhibitor, aphidicolin. 
Fig. 19 shows that γH2AX accumulates on the ERE chromatin at 15 min after 
E2 induction of transcription. Under the same conditions γH2AX  levels do 
not change on a reference promoter region of H19 gene, which we use as 
control.  
 We do not know if the band seen in Fig19b right panel reflects a constitutive 
presence of H2AX on this gene or it is  specific of a late replicating origins, 
due to hypermethylation of H19 gene.  
  Inhibition of replication by aphidicolin drastically reduces the amount of 
γH2AX on ERE (Fig. 19 a, b). It is worth noting that on the H19 gene there 
was a complete loss of γH2AX , suggesting that the accumulation of DSBs is 
dependent on active local replication. The lower levels of γH2AX on the ERE 
region at 15 min after E2 suggest a rapid repair of the DSB by active 
transcription. We suggest that 15’ after E2 exposure,  the initiation complex is 
fully formed, functional and able to repair local DNA lesions. 
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Figure 19: a.b.c. γH2AX levels on PS2  ERE  by qChIP in hormone-starved MCF-7 cells after E2 
activation at the indicated times (15’, 30’, 60’) in presence and in absence of aphidicolin. d. γH2AX 
levels on H19. Differences between treatments were tested for statistical significance using Student’s 
matched pairs t test: *P<0.05 as compared with the each untreated control. 
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5. DISCUSSION 
 
DNA Methylation cycles on promoters of estrogen induced genes 
 
 CpG methylation is not only a stable epigenetic mark but also an integral 
component of transcription. The DNA of the ERE –promoter region of PS2 
gene is subjected to cycles of methylation during the earliest phases of 
transcription induced by E2. 
This has been noted earlier but so far it is not known the biological 
significance (Metivier et al. 2003).  
 The data reported indicate that DNMT1 and 3a are recruited to the ERE 
promoter of TFF1 in a cyclical fashion (Fig.13, 15). Since both enzymes are 
involved also in replication, the recruitment to the ERE chromatin does not 
discriminate between DNA replication or transcription. However, inhibition 
of replication by aphidicolin (Fig. 17) prevents and delays DNMT1 not 
DNMT3a recruitment on the ERE chromatin, suggesting that DNMT3a is 
indeed directly involved in E2-induced transcription. 
 
 
DNMT3a  and active demethylation during E2-induced transcription 
 
The level and pattern of 5-meC are determined by both DNA methylation and 
demethylation processes. Demethylation of DNA can be passive and/or 
active.  
Passive DNA demethylation occurs when maintenance methyltransferases are 
inactive during the cell cycle following DNA replication, which results in a 
retention of the unmethylated state of the newly synthesized strand.  
Active DNA demethylation involves one or more enzymes and can occur 
independently of DNA replication.  
Evidence suggests that active DNA demethylation in mammals is also 
achieved, at least in part, by a base excision repair pathway.  
More specifically, it has been proposed that candidate deaminases include 
AID and APOBEC1 can convert 5-meC to T through deamination; the 
resulting T is then removed by a G/T mismatch base excision repair pathway 
(Zhu 2009).  
Recently, a new class of enzymes that participates to the demethylation of 
mCpG has been discovered. Tet ( ten-eleven translocation) enzymes oxidize 
methyl to 5’hydroxylmethyl cytosine, which can be either passively 
eliminated through replication (passive demethylation) or actively removed 
by base excision repair enzyme TDG (active demethylation).  
Our data discriminate the role of DNMT1 and DNMT3a on transcription, 
because the recruitment of DNMT3a to the ERE was independent on 
replication. Collectively, our data indicate that the DNMT3a on ERE 
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chromatin participates actively to transcription. We suggest that DNMT3a 
methylates CpGs that will be oxidized by Tet enzymes. 
 
 
Histone H3 K9 methylation cycles on promoters of estrogen induced 
genes  
 
 The DNA methylation cycles appears to be linked to the  histone H3 
methylatio demethylation cycles on the  ERE. Methylated H3K9 marks the 
promoter and the ERE chromatin in E2-inducible genes. Upon activation of 
E2, H3K9 is rapidly and transiently demethylated by LSD1 (Figure 12). 
LSD1 is a histone demethylase, which is recruited to the ERE sites and 
actively demethylates H3K4 and H3K9 (Perillo , 2008).  
 By interacting with diverse cofactors and catalyzing demethylation of mono- 
and di-methylated H3K4 or H3K9, LSD1 is capable of either repressing or 
activating target genes (Metzger and Schule 2007; Shi 2007). The 
demethylation of H3K9 induced by E2 is rapidly reversed after 90’(Figure 
12). H3K9 demethylation cycles, as well as the recruitment of the associated 
factors and DNMTs enzymes, can be detected only under stringent 
conditions, in which transcription initiation is synchronized.  
 
 
Recruitment of DNA methyltransferase to the transcription initiation 
complex 
 
Transcriptional activation involves the initial recognition of key regulatory 
DNA elements at promoters by sequence-specific DNA-binding activators 
and the core transcription machinery, along with the recruitment of essential 
cofactors (Lemon and Tjian 2000; Naar et al. 2001; Roeder 2005; Fong et al. 
2012). 
Estrogen-driven transcription triggers demethylation by LSD1 of H3K9me2, 
inducing DNA (G) oxidation (Perillo et al. 2008). Simultaneously, on the 
same sites DNMT1, 3a, DNA methyltransferase enzymes, are recruited and 
stimulate a wave of methylation of CpGs. We propose that methylated CpGs 
and oxidized Gs in the target sites during transcription initiation are processed 
by BER and NER enzymes restoring the correct G and the unmethylated C. 
 Our data provide evidence that both DNA methyltransferases are essential 
for E2-mediated transcription, since perturbing the levels of DNMT1 (Fig. 
18) and 3a (not shown), the expression of E2 targets, is inhibited. 
Furthermore, we know that in the first round of E2-dependent transcription 
BER and oxidative enzymes are recruited with the same kinetics shown by 
DNMT3a (Perillo et al. 2008; Kim  2009; Amente et al. 2010), suggesting 
that histone H3 demethylation,  oxidation, DNA methylation and DNA repair 
are linked. 
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 Furthermore, we have recently reported that the transcription machinery 
removes de novo DNA methylation induced by DNA damage and 
homologous repair (HDR, Homologous Dependent Repair) and that silencing 
of DNMT3a decreases HDR induced methylation (Morano et al. 2013).  
We do not know if these data can be extended to other nuclear receptors, but 
recent results obtained by analyzing transcription induction by retinoic acid 
suggest that histone demethylation and DNA oxidation are necessary for 
looping of chromatin during transcription initiation (Zuchegna et al. 
submitted). 
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6. CONCLUSIONS 
 
The data presented illustrate the association between DNA methylation and 
histone H3 methylation cycles. More specifically, we find that DNA 
methylation cycles of 15’-30’ correspond to demethylation of histone H3 
lysine 9 and methylation of lysine 4 occurring in the first round of 
transcription.  
 Inhibition of DNA or histone H3 methylation-demethylation processes alters 
the normal transcriptional events suggesting a mechanistic relation between 
DNA and H3 methylation and changes of chromatin leading to transcription 
initiation.  
 The same modifications of estrogen-induced genes occur in E boxes of Myc-
induced genes (de-methylation of H3K4-K9, accumulation of OGG1 and 
OxodG and APE1)(Amente et al. 2010; Amente et al. 2011).  
 We believe that in cancer cells, highly transcribed genes (such as E box Myc 
or estrogen-induced genes), are extremely sensitive to disruption of 
methylation-oxidation cycles and may accumulate mutations. 
   Furthermore, these studies offer a new window to target highly transcribed 
genes in cancer. For example, by using drugs that target both repair and 
oxidation enzymes, we may be able to selectively inhibit highly transcribed 
genes th ERE by inducing apoptotic responses in tumors cells. Also, 
inhibition of transcription in our system may be used to screen for drugs that 
selectively kill cancer cells that are oxidation-adapted (Watson JD 2013). 
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